1 recruiting, 1 suspended. 2 Phase 2, 1 Phase 3.
| Phase | Trials | Status |
|---|---|---|
| Phase 2 | 2 | Recruiting 1, Suspended 1 |
| Phase 3 | 1 | Suspended 1 |
Follow Anxiety Depression: new trials by email Literature Review of Anxiety Depression trials Research Report on Anxiety Depression
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Neuroactive Steroid to Treat Depressed Mood: A Trial for People With HIV Placebo, Pregnenolone - Major Depressive Disorder, Anxiety Depression | Phase 2 | Recruiting | Massachusetts General Hospital | 120 | 2023-03-03 | 2025-09-12 |
| CBD Oil for Reducing Emotional Impact of COVID-19 CBD Isolate, Full Spectrum CBD Oil, Broad-Spectrum CBD Oil - Anxiety Depression, Alcohol Abuse | Phase 2 / Phase 3 | Suspended | University of Texas at Austin | 200 | 2020-12-04 | 2023-11-22 |
Alcoholism (1) · COVID-19 (1) · Depression (1) · Depressive Disorder, Major (1) · Fractures, Stress (1) · Parasomnias (1) · Substance-Related Disorders (1)
Mental Disorders (2) · Alcohol-Related Disorders (1) · Behavior (1) · Behavioral Symptoms (1) · Chemically-Induced Disorders (1) · Coronaviridae Infections (1) · Coronavirus Infections (1) · Depressive Disorder (1) · Fractures, Bone (1) · Infections (1) · Lung Diseases (1) · Mood Disorders (1) · Nervous System Diseases (1) · Nidovirales Infections (1) · Pneumonia (1)
Neurosteroids (1) · Pregnenolone (1)
Massachusetts General Hospital (1) · University of Texas at Austin (1)
United States (2)
Michael J Telch, Ph.D. (1) · Shibani S. Mukerji, MD, PhD (1)
R01MH131194 (1)